Skip to main content
. 2022 Feb 11;12:2322. doi: 10.1038/s41598-022-05857-w

Figure 1.

Figure 1

sGRP78 expression on bone marrow cells of pediatric individuals with newly diagnosed B-ALL. (A) Acute lymphocytic leukemia cell lines were stained with anti-GRP78 antibody and representative experiments of each cell line are depicted. (B) Statistical representation of cell surface GRP78+ cells in leukemic cells lines is shown. Data are the mean plus SEM of n = 3. Statistical analysis was performed by One-way ANOVA, p < 0.0001. (C) Gating strategy for sGRP78+ cells analysis from bone marrow derived cells of pediatric individuals with B-ALL and controls (BM-CTL). (D) Statistical representation of cell surface GRP78+ cells in BM-CTL (n = 4) and B-ALL (n = 43). Statistical analysis was performed by two-tailed Mann–Whitney U test, *p < 0.05, **p < 0.01.